tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Narumi Nakagiri, 7 are a HOLD (46.67%), 8 are a BUY (53.33%).
Analyst Narumi Nakagiri, currently employed at DAIWA, carries an average stock price target met ratio of 90% that have a potential upside of 11.99% achieved within 113 days.
Narumi Nakagiri’s has documented 29 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MRK, Merck mpany at 12-Aug-2026.
Analyst best performing recommendations are on JNJ (JOHNSON & JOHNSON).
The best stock recommendation documented was for JNJ (JOHNSON & JOHNSON) at 7/23/2024. The price target of $150 was fulfilled within 2 days with a profit of $6.77 (4.73%) receiving and performance score of 23.63.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Aug-2026
$500
$96.96 (24.06%)
$450
Buy Since 06-Sep-2023
$425
$21.96 (5.45%)
$320
24 days ago
(10-Sep-2026)
1/2 (50%)
$42.53 (11.12%)
797
Buy Since 12-Apr-2024
$450
$46.96 (11.65%)
$450
26 days ago
(08-Sep-2026)
32/34 (94.12%)
$56.83 (14.45%)
567
Hold Since 07-Oct-2024
$400
$-3.04 (-0.75%)
$400
26 days ago
(08-Sep-2026)
32/35 (91.43%)
$6.83 (1.74%)
269
Hold Since 10-Jan-2025
$435
$31.96 (7.93%)
$400
1 months ago
(04-Sep-2026)
20/21 (95.24%)
$-2.23 (-0.51%)
307
Which stock is Narumi Nakagiri most bullish on?
What Year was the first public recommendation made by Narumi Nakagiri?
